Anti-VEGF Advances in Retina

Category: Medical

ASO Keyword Dashboard

Tracking 25 keywords for Anti-VEGF Advances in Retina in Apple App Store

Developer: Med Learning Group Category: medical

Anti-VEGF Advances in Retina tracks 25 keywords (no keywords rank yet; 25 need traction). Key metrics: opportunity 70.9, difficulty 37.2.

Tracked keywords

0 ranked • 25 not ranking yet

Top 10 coverage

—

Best rank — • Latest leader —

Avg opportunity

70.9

Top keyword: optimize

Avg difficulty

37.2

Lower scores indicate easier wins

Opportunity leaders

optimize

Opportunity: 73.0 • Difficulty: 40.9 • Rank —

Competitors: 87
67.1
reduce

Opportunity: 73.0 • Difficulty: 41.9 • Rank —

Competitors: 138
68.4
generation

Opportunity: 73.0 • Difficulty: 40.1 • Rank —

Competitors: 106
65.6
role

Opportunity: 73.0 • Difficulty: 39.5 • Rank —

Competitors: 89
64.1
growth

Opportunity: 73.0 • Difficulty: 40.2 • Rank —

Competitors: 110
66.4

Unranked opportunities

optimize

Opportunity: 73.0 • Difficulty: 40.9 • Competitors: 87
reduce

Opportunity: 73.0 • Difficulty: 41.9 • Competitors: 138
generation

Opportunity: 73.0 • Difficulty: 40.1 • Competitors: 106
role

Opportunity: 73.0 • Difficulty: 39.5 • Competitors: 89
growth

Opportunity: 73.0 • Difficulty: 40.2 • Competitors: 110

High competition keywords

experience

Total apps: 122,446 • Major competitors: 2,106

Latest rank: — • Difficulty: 52.1
management

Total apps: 42,389 • Major competitors: 304

Latest rank: — • Difficulty: 46.8
options

Total apps: 24,959 • Major competitors: 444

Latest rank: — • Difficulty: 45.3
related

Total apps: 20,280 • Major competitors: 220

Latest rank: — • Difficulty: 44.1
program

Total apps: 17,296 • Major competitors: 220

Latest rank: — • Difficulty: 43.5

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
experience	66	100	52	85 122,446 competing apps Median installs: 150 Avg rating: 4.2	—	—	2,106 major competitor apps
management	69	100	47	77 42,389 competing apps Median installs: 75 Avg rating: 4.1	—	—	304 major competitor apps
program	72	100	44	71 17,296 competing apps Median installs: 150 Avg rating: 4.1	—	—	220 major competitor apps
patients	72	100	38	62 5,418 competing apps Median installs: 100 Avg rating: 4.1	—	—	32 major competitor apps
related	71	100	44	72 20,280 competing apps Median installs: 100 Avg rating: 4.1	—	—	220 major competitor apps
immersive	72	100	43	69 13,550 competing apps Median installs: 250 Avg rating: 4.2	—	—	293 major competitor apps
optimize	73	100	41	67 10,231 competing apps Median installs: 100 Avg rating: 4.3	—	—	87 major competitor apps
reduce	73	100	42	68 12,154 competing apps Median installs: 150 Avg rating: 4.2	—	—	138 major competitor apps
generation	73	100	40	66 8,322 competing apps Median installs: 150 Avg rating: 4.2	—	—	106 major competitor apps
role	73	100	40	64 6,789 competing apps Median installs: 150 Avg rating: 4.1	—	—	89 major competitor apps
growth	73	100	40	66 9,316 competing apps Median installs: 150 Avg rating: 4.4	—	—	110 major competitor apps
strategies	72	100	38	63 5,537 competing apps Median installs: 200 Avg rating: 4.3	—	—	85 major competitor apps
dosing	68	100	24	40 259 competing apps Median installs: 200 Avg rating: 4.1	—	—	1 major competitor apps
reality	73	100	40	65 8,062 competing apps Median installs: 100 Avg rating: 4.1	—	—	94 major competitor apps
options	71	100	45	74 24,959 competing apps Median installs: 200 Avg rating: 4.2	—	—	444 major competitor apps
enhanced	73	100	41	67 10,313 competing apps Median installs: 200 Avg rating: 4.2	—	—	222 major competitor apps
factor	72	100	36	58 3,030 competing apps Median installs: 150 Avg rating: 4.1	—	—	63 major competitor apps
treatment	72	100	38	62 5,341 competing apps Median installs: 100 Avg rating: 4.2	—	—	41 major competitor apps
optimizing	71	100	32	54 1,668 competing apps Median installs: 100 Avg rating: 4.2	—	—	10 major competitor apps
presents	72	100	38	62 5,380 competing apps Median installs: 100 Avg rating: 4.1	—	—	69 major competitor apps
vascular	67	100	22	37 161 competing apps Median installs: 100 Avg rating: 4.3	—	—	0 major competitor apps
reality experience	68	100	23	39 203 competing apps Median installs: 100 Avg rating: 3.9	—	—	0 major competitor apps
outcomes	71	100	33	53 1,535 competing apps Median installs: 100 Avg rating: 4.3	—	—	8 major competitor apps
diabetic	68	100	24	39 208 competing apps Median installs: 150 Avg rating: 4.2	—	—	3 major competitor apps
therapies	68	100	24	41 263 competing apps Median installs: 75 Avg rating: 4.2	—	—	2 major competitor apps

App Description

This Immersive Enhanced Reality experience investigates the role of vascular endothelial growth factor (VEGF) in diabetic macular edema (DME), neovascular age-related macular degeneration (nAMD), and retinal vein occlusion (RVO). The program presents management options for retinal disease, optimizing anti-VEGF treatment regimens through dosing strategies and next-generation anti-VEGF therapies to reduce treatment burden, and optimize outcomes in patients with these retinal conditions.